Developing model language for disclosing financial interests to potential clinical research participants

IRB Ethics and Human Research

Volumn 29, Issue 1, 2007, Pages 1-5

  Weinfurt, Kevin P ^a,b   Allsbrook, Jennifer S ^b   Friedman, Joëlle Y ^b   Dinan, Michaela A ^b   Hall, Mark A ^c   Schulman, Kevin A ^a,b   Sugarman, Jeremy ^d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMICS; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; RESEARCH SUBJECT; REVIEW; STANDARD;

BIOMEDICAL RESEARCH; DISCLOSURE; ETHICS COMMITTEES, RESEARCH; HUMANS; RESEARCH SUBJECTS;

EID: 33846821994     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Angell M. Is academic medicine for sale? NEJM 2003;342.(20):1516- 1518;
2. Bodenheimer T. Uneasy alliance - clinical investigators and the pharmaceutical industry. NEJM 2000;342.(20):1539-1544;
3. Krimsky S. Science in the Private Interest. Lanham, MD: Rowman & Littlefield Publishers, Inc., 2003;
4. Shalala D. Protecting research subjects - what must be done. NEJM 2000;343(11):808-810.
5. AAMC Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress II: Principles and recommendations for oversight of an institution's financial interests in human subjects research. Academic Medicine 2003;78(2.):237-145;
6. Financial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection. Federal Register 2004;69:26393-26397;
7. AAMC Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress I: Policy and guidelines for the oversight of individual financial interests in human subjects research. Academic Medicine 2003;78(2):225-236.
8. Weinfurt KP, Dinan, MA, Allsbrook JS, et al. Policies of academic medical centers for disclosing conflicts of interest to potential research subjects. Academic Medicine 2005;81(2):113-118.
9. Kim SY, Millard RW, Nisbet P, et al. Potential research participants' views regarding researcher and institutional financial conflicts of interest. Journal of Medical Ethics 2004;30(1):73-79;
10. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 2003;289(4):454-465;
11. Campbell EG, Moy B, Feibelmann S, et al. Institutional academic industry relationship: Results of interviews with university leaders. Accountability in Research 2004;11(2):103-118.
12. Weinfurt KP, Friedman JY, Allsbrook JS, et al. Views of potential research participants on financial conflicts of interest: Barriers and opportunities for effective disclosure. Journal of General Internal Medicine, 2006;21(9):901-906.
13. Marshall MF. National Human Research Protections Advisory Committee Response to DHHS Financial Relationships Draft Interim Guidance. August 2001. http://www.hhs.gov/ohrp/nhrpac/documents/fda.pdf.
14. See ref. 2, AAMC Task Force on Financial Conflicts of Interest in Clinical Research 1003.
15. Faden RR, Beauchamp TL. A History and Theory of Informed Consent. New York: Oxford University Press, 1986.
16. See ref. 8, Faden and Beauchamp 1986.
17. Wills GB. Cognitive Interviewing. Thousand Oaks, CA: Sage Publications, 2005.
18. See ref. 3, Weinfurt et al. 2005.